Clinical Trials on COVID-19, SARS-CoV-2 in Ireland
Total 127 results
-
University of BolognaCharite University, Berlin, Germany; Institut National de la Santé Et de la... and other collaboratorsRecruitingSARS CoV 2 Infection | Vaccination; Infection | Breakthrough InfectionArgentina, Gabon, India, Ireland, Italy, Luxembourg, Netherlands, Spain
-
NYU Langone HealthNational Heart, Lung, and Blood Institute (NHLBI)RecruitingSARS-CoV2 InfectionUnited States, Puerto Rico
-
Gilead SciencesApproved for marketingSARS-CoV2 InfectionUnited States, Israel, Belgium, Spain, Australia, Denmark, Italy, Germany, France, Portugal, United Kingdom, Poland, Switzerland, Canada, Austria, Cyprus, Czechia, Estonia, Greece, Hungary, Iceland, Ireland, Lithuania, Netherlands, Romania and more
-
AstraZenecaActive, not recruitingCOVID-19, SARS-CoV-2United States, Belgium, Canada, France, Spain, Denmark, Thailand, Vietnam, Korea, Republic of, United Kingdom, Malaysia, Israel, Taiwan, Australia, Germany, Poland, Singapore, United Arab Emirates
-
BioNTech SEPfizerCompletedSARS-CoV-2 Infection, COVID-19United States, Spain, Finland, Poland, Mexico, Brazil
-
The Miriam HospitalCompletedSARS-CoV 2 | Covid19 | Dexamethasone | Steroids | CorticosteroidsUnited States
-
aTyr Pharma, Inc.CompletedSARS-CoV-2 (COVID-19) Severe PneumoniaUnited States, Puerto Rico
-
NovavaxCompletedCOVID-19 | SARS-CoV-2 InfectionUnited States
-
LumiraDx UK LimitedSuspendedCOVID-19 | SARS-CoV-2 | Influenza A | Influenza BUnited States
-
Red Queen Therapeutics, Inc.PPDCompletedCOVID-19 | Infectious Disease | SARS CoV 2 Infection | Symptomatic COVID-19 Infection Laboratory-ConfirmedUnited States
-
ModernaTX, Inc.Completed
-
Partner Therapeutics, Inc.United States Department of DefenseCompleted
-
ModernaTX, Inc.Completed
-
AstraZenecaActive, not recruitingSARS-CoV-2United States, Belgium, United Kingdom, Brazil, Germany
-
BioNTech SEPfizerCompletedCOVID-19 | SARS-CoV-2 InfectionUnited States, Germany, Turkey, South Africa, Argentina, Brazil
-
Johns Hopkins UniversityNational Institute of Allergy and Infectious Diseases (NIAID); United States... and other collaboratorsCompletedSARS-CoV 2United States
-
ModernaTX, Inc.National Institute of Allergy and Infectious Diseases (NIAID); Biomedical Advanced...Completed
-
ModernaTX, Inc.Biomedical Advanced Research and Development AuthorityActive, not recruitingSARS-CoV-2United States, Dominican Republic
-
ModernaTX, Inc.RecruitingSARS-CoV-2United States, Puerto Rico
-
AstraZenecaIqvia Pty LtdCompletedPhase III Double-blind, Placebo-controlled Study of AZD1222 for the Prevention of COVID-19 in AdultsCOVID-19 | SARS-CoV-2United States, Chile, Peru
-
Regeneron PharmaceuticalsCompletedHealthy ParticipantsUnited States, Moldova, Republic of, Romania
-
Atea Pharmaceuticals, Inc.Active, not recruitingCOVID-19 | SARS CoV 2 InfectionUnited States, Argentina, Brazil, Canada, Germany, India, Japan, Latvia, Mexico, Netherlands, Pakistan, Philippines, Romania, South Africa, Spain, Sweden, Tunisia, Turkey, United Kingdom
-
ModernaTX, Inc.Completed
-
MedicagoActive, not recruitingSARS-CoV-2 InfectionUnited States, Canada, United Kingdom, Argentina, Brazil, Mexico
-
BioNTech SEPfizerCompletedCOVID-19 | SARS-CoV-2 InfectionUnited States, Brazil, South Africa, Germany, Canada, Israel
-
Cardiovascular Research Institute DublinActive, not recruitingCovid19 | Cardiomyopathies | SARS-CoV InfectionIreland
-
NYU Langone HealthNational Heart, Lung, and Blood Institute (NHLBI)RecruitingSARS-CoV-2 InfectionUnited States
-
National Institute of Allergy and Infectious Diseases...CompletedSARS-CoV-2 InfectionUnited States
-
BioNTech SEPfizerRecruitingCOVID-19 | Severe Acute Respiratory Syndrome Coronavirus 2 | SARS-CoV-2 VirusUnited States, Brazil, Puerto Rico
-
Northwell HealthCompletedCOVID | Sars-CoV2United States
-
MP Biomedicals, LLCEDP BiotechCompletedCOVID-19 | SARS-CoV2 InfectionUnited States
-
Partner Therapeutics, Inc.United States Department of DefenseCompletedCovid19 | SARS-CoV InfectionUnited States, Argentina
-
NovavaxDepartment of Health and Human ServicesCompletedCovid19 | SARS-CoV InfectionUnited States, Mexico, Puerto Rico
-
Cancer Trials IrelandTerminated
-
ModernaTX, Inc.Active, not recruitingA Study of mRNA-based Influenza and SARS-CoV-2 (COVID-19) Multi-component Vaccines in Healthy AdultsInfluenza | SARS-CoV-2United States
-
ModernaTX, Inc.CompletedInfluenza | SARS-CoV-2 | RSVUnited Kingdom, Australia, United States
-
Institute of Technology, CarlowActive, not recruitingAutism Spectrum Disorder | Cardiovascular HealthIreland
-
Beaumont HospitalRecruitingCOVID-19 | Pneumonia | Respiratory Failure | Pulmonary Disease | COPD | Community-acquired PneumoniaIreland
-
University Hospital, Basel, SwitzerlandCompletedCovid-19 | COVID-19 Related Psychosocial BurdenNorway, Spain, Ireland, United Kingdom, Portugal, Poland, Austria, Belgium, Canada, Finland, France, Germany, Greece, Iran, Islamic Republic of, Italy, Switzerland
-
National University of Ireland, Galway, IrelandSuspended
-
Kerecis Ltd.Completed
-
Janssen Vaccines & Prevention B.V.CompletedParticipants With or Without Stable Co-morbidities Associated With Progression to Severe COVID-19United States, United Kingdom, Belgium, Spain, France, Germany, Philippines, Brazil, Colombia, South Africa
-
Landspitali University HospitalCompleted
-
University College Hospital GalwayTerminatedCOVID19 | Mechanical Ventilation Complication | ARDS, HumanIreland
-
Children's Health IrelandQueen's University, Belfast; Cystic Fibrosis Foundation; European Cystic Fibrosis...Active, not recruiting
-
Bavarian NordicCompletedCOVID-19 DiseaseUnited States, Denmark, Belgium
-
University College Hospital GalwayRecruitingCovid19 | ARDS, Human | Ventilation Perfusion Mismatch | Lung Injury, AcuteIreland
-
CSL BehringCompletedCoronavirus Disease 2019 (COVID-19)United States
-
Laurent Pharmaceuticals Inc.Active, not recruitingCOVID-19 DiseaseUnited States, Canada
-
Janssen Vaccines & Prevention B.V.CompletedParticipants With or Without Stable Co-morbidities Associated With Progression to Severe COVID-19 at Different Stages of the ProtocolUnited States, Mexico, South Africa, Brazil, Chile, Colombia, Peru, Argentina